Assay discrepancies with highly purified factor VIII concentrates

Haemostasis
N J DawsonT W Barrowcliffe

Abstract

We have assayed two different monoclonal-antibody-purified concentrates (A and B) and one conventional concentrate (C), against the 3rd International Standard for factor VIII concentrate, using one-stage, two-stage and chromogenic methods. One-stage assays performed with immunodepleted plasmas gave lower potencies than with haemophilic plasma for all concentrates, though the discrepancies were most marked for the two highly purified products. The absence of von Willebrand factor in one of the immunodepleted plasmas appeared to contribute towards the low potencies observed. In addition, potencies of product A were 50% higher by one-stage assays (haemophilic plasma) than by two-stage or chromogenic methods. These results indicate the need for careful evaluation of assay methodologies for assessment of factor VIII:C activity in highly purified concentrates.

Citations

Sep 1, 1994·Journal of Biomedical Materials Research·G H RyuB Min
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·T W BarrowcliffeA R Hubbard
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·J M LusherD Hurst
Jun 1, 1993·British Journal of Haematology·G Kemball-CookT W Barrowcliffe
Jul 1, 1996·Haemophilia : the Official Journal of the World Federation of Hemophilia·A FarrugiaM Poulis
Dec 12, 2001·Clinical Pharmacokinetics·S Björkman, E Berntorp
Mar 1, 1991·American Journal of Hematology·R E WeinsteinF R Rickles
Apr 1, 1993·American Journal of Hematology·E D Gomperts, D Menache
Oct 30, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·T W Barrowcliffe
Apr 26, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·S KitchenK Mertens
Nov 23, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·J M SommerG F Pierce
Nov 1, 1992·The Journal of Pediatrics·C S MannoA R Cohen
Mar 27, 2010·Biologicals : Journal of the International Association of Biological Standardization·Sanj Raut, Anthony R Hubbard
Jan 27, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·M JacqueminK Peerlinck
Apr 24, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·K B ThomasA Schoppmann
Apr 12, 2020·European Journal of Haematology·Emmanuelle JeanpierreUNKNOWN French Study Group on the Biology of Hemorrhagic Diseases (the BIMHO group)
Apr 26, 2006·Journal of Thrombosis and Haemostasis : JTH·S CinottiM Morfini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

British Journal of Haematology
T B Kirkwood, T W Barrowcliffe
Haemophilia : the Official Journal of the World Federation of Hemophilia
T W BarrowcliffeA R Hubbard
Journal of Thrombosis and Haemostasis : JTH
A R HubbardFactor VI I I and Factor IX Subcommittee of The Scientific and Standardisation Committee of The International Society on Thr
© 2022 Meta ULC. All rights reserved